BREAKING
BIO-key International, Inc. (BKYI) Reports Q4 Earnings 30 minutes ago SiTime Corporation (SITM) Jumps 8.9% to $339.00 33 minutes ago Purple Innovation, Inc. (PRPL) Reports Q4 Earnings 50 minutes ago TON Strategy Company (VERB) Reports FY2025 Earnings 1 hour ago Allarity Therapeutics, Inc. (ALLR) Reports FY2025 Earnings 2 hours ago McCormick & Company, Incorporated (MKC) Q1 2026 Earnings Recap 2 hours ago J.Jill, Inc. (JILL) Q4 Earnings: Misses on EPS, Revenue Recap 2 hours ago OS Therapies Incorporated (OSTX) Reports FY2025 Earnings 2 hours ago Palvella Therapeutics, Inc. (PVLA) Reports FY2025 Earnings 2 hours ago B.O.S. Better Online Solutions Ltd. (BOSC) Reports Q4 Earnings 2 hours ago BIO-key International, Inc. (BKYI) Reports Q4 Earnings 30 minutes ago SiTime Corporation (SITM) Jumps 8.9% to $339.00 33 minutes ago Purple Innovation, Inc. (PRPL) Reports Q4 Earnings 50 minutes ago TON Strategy Company (VERB) Reports FY2025 Earnings 1 hour ago Allarity Therapeutics, Inc. (ALLR) Reports FY2025 Earnings 2 hours ago McCormick & Company, Incorporated (MKC) Q1 2026 Earnings Recap 2 hours ago J.Jill, Inc. (JILL) Q4 Earnings: Misses on EPS, Revenue Recap 2 hours ago OS Therapies Incorporated (OSTX) Reports FY2025 Earnings 2 hours ago Palvella Therapeutics, Inc. (PVLA) Reports FY2025 Earnings 2 hours ago B.O.S. Better Online Solutions Ltd. (BOSC) Reports Q4 Earnings 2 hours ago
ADVERTISEMENT
Breaking News

Purple Innovation, Inc. (PRPL) Reports Q4 Earnings

Purple Innovation, Inc. (PRPL) posted Q4 2025 adjusted EPS of -$0.02.

March 31, 2026 1 min read

Purple Innovation, Inc. (PRPL) posted Q4 2025 adjusted EPS of -$0.02.

PRPLPRPL|EPS -$0.02|Rev $140.7M|Net Loss $3.2M

Purple Innovation, Inc. (PRPL) posted Q4 2025 adjusted EPS of -$0.02. Revenue totaled $140.7M for the quarter. Revenue was up 9.1% year-over-year.

Purple Innovation, Inc. is a Furnishings, Fixtures & Appliances company. Adjusted EBITDA was $9M for the quarter. Bottom line showed a net loss of $3.2M.

Looking ahead, the company projected FY 2026 adjusted EBITDA in the $20M to $30M range. For FY 2026, management expects revenue of $500M to $520M. Wall Street consensus stands at 5 buy, 4 hold, 0 sell.

This article was generated with the assistance of AI technology and reviewed for accuracy. AlphaStreet may receive compensation from companies mentioned in this article. This content is for informational purposes only and should not be considered investment advice.

ADVERTISEMENT